Zynerba: Q1 Earnings Snapshot
Posted May 12, 2021 07:57:34 AM.
Last Updated May 12, 2021 08:09:14 AM.
DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Wednesday reported a loss of $8 million in its first quarter.
On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 20 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
The company’s shares closed at $4.16. A year ago, they were trading at $4.45.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE
The Associated Press